###begin article-title 0
Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 484 488 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 503 507 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 521 525 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 280 283 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) associated nasopharyngeal cancer (NPC) is an important squamous cell cancer endemic in Southeast Asia and the Far East and can be considered a multifactorial genetic disease. This research explores potential associations between nasopharyngeal epithelial EBV receptor and NPC susceptibility. To prove the hypothesis, we evaluated two candidate genes, complement receptor 2 (CR2) and polymeric immunoglobulin receptor (PIGR) by using 4 SNPs, CR2IVS2-848C-->T, PIGRIVS3-156G-->T, PIGR1093G-->A and PIGR1739C-->T, to genotype 175 cases and 317 controls, divided into Thai, Chinese and Thai-Chinese based on their respective ethnic origins.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 381 385 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
The results obtained indicated that PIGR is an NPC susceptibility gene. The risk association pertaining to each ethnic group was detected for homozygous PIGR1739C with a significant ethnic group adjusted OR (95%CI) of 2.71(1.72-4.23) and p < 0.00001. Haplotype of the two missense PIGR SNPs, 1093G-->A and 1739C-->T, and sequence analyses have confirmed the role of the nucleotide PIGR1739 and excluded possibility of an additional significant nonsynonymous NPC susceptibility SNP.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 92 95 <span type="species:ncbi:10376">EBV</span>
###xml 139 142 <span type="species:ncbi:10376">EBV</span>
###xml 340 343 <span type="species:ncbi:10376">EBV</span>
We present genetic evidence leading to hypothesize a possibility of PIGR to function as the EBV nasopharyngeal epithelium receptor via IgA-EBV complex transcytosis failure. The PIGR1739C-->T is a missense mutation changing alanine to valine near endoproteolytic cleavage site. This variant could alter the efficiency of PIGR to release IgA-EBV complex and consequently increase the susceptibility of populations in endemic areas to develop NPC.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 946 947 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 997 1001 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA </italic>
###xml 1026 1032 1026 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP2E1</italic>
###xml 1281 1282 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1405 1406 1405 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1525 1531 1525 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP2E1</italic>
###xml 1616 1618 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1634 1636 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2104 2106 2104 2106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 624 627 <span type="species:ncbi:10376">EBV</span>
###xml 1222 1230 <span type="species:ncbi:9606">patients</span>
###xml 1261 1264 <span type="species:ncbi:10376">EBV</span>
###xml 1469 1477 <span type="species:ncbi:9606">patients</span>
###xml 1693 1696 <span type="species:ncbi:10376">EBV</span>
###xml 1847 1850 <span type="species:ncbi:10376">EBV</span>
###xml 1923 1926 <span type="species:ncbi:10376">EBV</span>
Nasopharyngeal cancer (NPC [MIM 161550]) constitutes an endemic multifactorial genetic disease [1]. Whereas the disease is quite rare in the Western world, it occurs at high frequencies in Southern China, Southeast Asia, and among the Greenland Inuit. The highest aged-adjusted incidence has been reported in South China to be 30-50/100,000. Intermediate incidence has been noted in South East Asia with a ratio of 3/100,000 among Thais and 10/100,000 among Thais of Chinese extraction, respectively [2]. Regarding environmental carcinogenesis, both viral and chemical carcinogens contribute to NPC with Epstein Barr virus (EBV) as the most important etiological factor. The single clonally derived viral genome can be found in all endemic NPC cells [3-5]. On the other hand, several reports indicate that consuming salty fish or preserved food and thus concentrating chemical carcinogens such as nitrosamine, can promote the development of NPC [6,7]. Interestingly, two NPC susceptibility genes, HLA and cytochrome P450 2E1 (CYP2E1), were discovered based on their hypothesized relationship with environmental factors contributing to NPC etiology. HLA was first studied in Singapore as this gene would be responsible for patients' immune response to cancer or EBV infected cells [8]. In particular HLA A2 and B46 conferred a high relative risk as to NPC development according to various reports in Asia [9]. In addition, NPC development was proposed to correlate with patients' history of consuming preserved food and hence CYP2E1, which metabolises nitrosamine, was studied revealing a risk association in Taiwan [10] and Thailand [11]. This research aims at exploring the genetic aspect of EBV entry into the nasopharyngeal epithelium (NE). This process not only requires specific host factors but also differentiates between the mechanisms of EBV carcinogenesis originating in epithelial and/or lymphoid cells. Whereas EBV-associated Burkitt's lymphoma is prevalent in Africa, populations demonstrating a higher risk for developing NPC do not show any significant increase in the lymphoma incidence [12].
###end p 8
###begin p 9
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 873 878 873 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1467 1469 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1517 1521 1517 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 1524 1529 1524 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 17 20 <span type="species:ncbi:10376">EBV</span>
###xml 257 260 <span type="species:ncbi:10376">EBV</span>
###xml 306 309 <span type="species:ncbi:10376">EBV</span>
###xml 683 686 <span type="species:ncbi:10376">EBV</span>
###xml 708 711 <span type="species:ncbi:10376">EBV</span>
###xml 807 810 <span type="species:ncbi:10376">EBV</span>
###xml 906 909 <span type="species:ncbi:10376">EBV</span>
###xml 1098 1101 <span type="species:ncbi:10376">EBV</span>
###xml 1161 1169 <span type="species:ncbi:9606">patients</span>
###xml 1656 1664 <span type="species:ncbi:9606">patients</span>
The mechanism of EBV entry into the NE has not yet been conclusively elucidated but at least two receptors, complement receptor type 2 (CR2) and polymeric immunoglobulin receptor (PIGR), have been proposed. CR2 is an integral membrane glycoprotein to which EBV can bind and thus infect B-lymphocytes [13]. EBV can infect recombinant epithelial cells expressing CR2 especially when in contact with virus-producing lymphocytes [14,15]. In addition, there has been a study reporting CR2 expression in embryonic NE cell by RT-PCR [16]. As for PIGR, the protein can be discovered on NE, interestingly as a pneumoccocus receptor, [17] where it mediates endocytosis and transcytosis of IgA-EBV complexes to deliver EBV into the luminal surface [18]. The viral translocation process can fail and consequently cause EBV infection if the epithelium loses its polarity or has mutated PIGR [19,20]. In addition to NE, EBV was reported to enter NPC in vitro depending on the presence of viral specific IgA [21]. Interestingly, serology studies indicate indirectly that PIGR is involved in NPC development. High EBV-IgA titers can be detected in a significant portion of NPC patients and the test has significant predictive role in diagnosing the disease [22]. Based on specific endemic distribution, NPC susceptibility genes can be hypothesized to originate from ancestor alleles. Hence, this study has been designed candidate-gene approaches for studying complex genetic traits [23]. The specific aim has been to explore whether CR2 or PIGR might be NPC susceptibility genes by determining the risk association between their DNA polymorphisms and haplotypes among NPC patients and controls from several individuals of high-risk ethnic origin.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
PIGR and CR2 SNPs NPC case-control study
###end title 11
###begin p 12
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 355 359 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 373 377 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 391 395 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 425 428 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 466 468 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 475 479 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 506 508 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 565 569 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 583 587 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 665 669 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 740 744 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 813 817 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 873 876 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 891 895 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 913 917 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 959 963 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 986 987 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
The study explored the risk of association between CR2 or PIGR DNA polymorphisms and NPC phenotype. Both the 175 patients and 317 controls were separated into Thai, Chinese and Thai-Chinese, according to their grandparents' ethnic origin so that each group would have a higher probability of shared ancestors. The genotype of four SNPs, CR2IVS2-848C-->T, PIGRIVS3-156G-->T,PIGR1093G-->A and PIGR1739C-->T, were investigated. CR2IVS2-848C-->T located near exon 1, 2 [24], and PIGRIVS3-156G-->T in intron 3 [25], have previously been published as RFLP polymorphisms. PIGR1093G-->A and PIGR1739C-->T, on exon 5 and 7, respectively, were selected from a SNP database . PIGR1093G-->A displays an amino acid alteration from glycine to serine and PIGR1739C-->T from alanine to valine, respectively. No missense SNP from CR2 has recently been reported by genbank. The amplicons of CR2IVS2-848C-->T, PIGRIVS3-156G-->T and PIGR1739C-->T were genotyped by PCR-RFLP, and PIGR1093G-->A by ARMS (fig 1).
###end p 12
###begin p 13
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 79 84 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TaqI </italic>
###xml 249 254 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 336 340 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 372 378 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PvuII </italic>
###xml 568 572 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 620 625 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HgaI </italic>
###xml 922 926 918 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
SNPs analysis of CR2 and PIGR. (A) The CR2IVS2-848C-->T was distinguishable by TaqI restriction. Digestion of the 1241 bp amplicon yielded two DNA fragments, 750 and 491 bp. Lane 1, 3 and 4 were homozygous -/- and lane 2 was heterozygous +/-. (B-D) PIGR polymorphisms was investigated by PCR-RFLP and ARMS. (B) RFLP analysis of 1392 bp PIGRIVS3-156G-->T PCR products with PvuII digestion yielded 1163 and 229 bp DNA fragments. Lane 1,2,4,7 and 8 were heterozygous +/-, samples 3,9 and 12 were homozygous +/+, and samples 5,6,10 and 11 were homozygous -/-. (C) RFLP of PIGR1739C of the 220 bp PCR product was analyzed by HgaI digestion and yielded two fragments of 180 and 40 bp, respectively, whereas 1739T remained as 220 bp DNA product. Heterozygous CT yielded 220,180 and 40 bp fragments. Negative control in lane1; homozygous CC in lanes 2,5,7 and 8; heterozygous CT in lanes 3 and 6, and homozygous TT in lane 4. (D) PIGR1093G-->A was detected by ARMS. Negative control in lanes 1 and 2 for primer sets A and B. Samples S1, 2, 3, were homozygous 1093G. Samples S4, 5, 6 were homozygous 1093A, and S7 was heterozygous.
###end p 13
###begin p 14
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 201 205 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 223 227 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 244 245 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 266 270 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 575 579 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 677 679 667 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 743 748 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 893 894 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 980 981 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 994 997 984 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 999 1002 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 1268 1269 1256 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1308 1312 1296 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 1384 1389 1372 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Upon comparison between the frequency of these alleles in patients and controls of identical ethnic origin, Thai or Chinese, a significant risk association to PIGR1739C-->T was detected but neither to PIGRIVS3-156G-->T nor PIGR1093G-->A (table 1). The OR (95%CI) of PIGR1739C-->T in the Thai group was 1.70(1.03-2.82) and 2.35(1.11-5.07) among Chinese NPC cases with 1739C as the susceptible allele. When we analyzed all three ethnic groups and used Mantel-Haenszel stratification method to correct for ethnic matched control, the difference between crude and adjusted OR of PIGR1739C-->T was less than 15%. The significant race adjusted OR (95%CI) is 2.26(1.51-3.25) with the p value was less than 0.0001. The NPC susceptibility conferred by PIGR requires homozygous 1739C to increase the likelihood of NPC development, with the race adjusted OR(95%) = 2.71(1.72-4.23) and p < 0.00001 (table 2). The similar significant contribution can be demonstrated with all subgroups (table 2). Regarding CR2, CR2IVS2-848C-->T demonstrated no considerable correlation with NPC when analyzing Thai, Chinese or including all cases. Nevertheless significant OR (95%CI) = 1.80(1.14-3.03) with p < 0.05 could be demonstrated upon adjusting for age, sex and ethnic of all cases (table 1). This data suggests that the role of CR2 as an NPC susceptibility gene need further evaluation while the role of PIGR is crucial.
###end p 14
###begin p 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
CR2 and PIGR polymorphisms in NPC cases and control subjects.
###end p 15
###begin p 16
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 81 85 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 218 222 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 258 262 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 350 354 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 365 369 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 376 380 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 441 443 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
###xml 453 455 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 466 468 462 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
Total is Thai, Chinese and Thai-Chinese cases and controls. CR2IVS2-848C-->T and PIGRIVS3-156G-->T allele+ and allele- are digested and not digested with the restriction enzyme, respectively. G and A are nucleotide at PIGR1093, and C and T are nucleotide at PIGR1739, respectively. OR (95%CI) = odd ratios and 95% confidence interval of allele CR2+, PIGRIVS3-156G, PIGR1093G, PIGR1739C when compared with the other alleles of the same SNPs. 1 p < 0.05, 2 p < 0.001, 3 p < 0.0001
###end p 16
###begin p 17
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
Risk of nasopharyngeal carcinoma associated with PIGR1739C-->T genotype according to different models of inheritance.
###end p 17
###begin p 18
###xml 263 265 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
CC and TT are the homozygous C and T at nucleotide 1739, respectively. CT is the heterozygous at nucleotide 1739. Total is Thai, Chinese and Thai-Chinese cases and controls. OR (95%CI) is odd ratios and 95% confidence interval between allele and compared allele, 1 p < 0.05, 2 p < 0.001, 3 p < 0.00001
###end p 18
###begin title 19
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
Haplotype analysis of two missense PIGR SNPs, 1093 G-->A and 1739 C-->T
###end title 19
###begin p 20
###xml 244 245 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 480 482 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 599 600 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
To further elucidate the relevance of the two missense SNPs as for NPC development, genotype data of 1093G-->A and 1739C-->T were tabulated into four haplotypes, 1093G-1739T (GT), 1093G-1739C (GC), 1093A-1739T (AT), and 1093A-1739C (AC) (table 3). The frequency of each haplotype based on its ethnic group was estimated by the EH program and distribution was compared between groups. Among the controls, there were no relevant difference between the Thai and the Chinese, yet the p values for the cases and the controls of both subgroups and the total were below 0.05 and 0.005, respectively (table 3).
###end p 20
###begin p 21
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
Haplotype frequencies of PIGR1093-1739, crude OR and ethnic group adjusted OR.
###end p 21
###begin p 22
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">23</sup>
Each haplotype frequency was calculated by the Estimating Haplotype-frequencies (EH) software program23. Total is Thai, Chinese and Thai-Chinese cases and controls. OR (95%CI) = odd ratios and 95% confidence interval between the tested haplotype and the other three alleles, The OR (95%CI) calculation used the estimated number from each haplotype number of cases and controls. The number of haplotypes in the total category were calculated from the summation of estimated haplotype number from each ethnic. GC, AC, GT, and AT are 1093G-1739C, 1093A-1739C, 1093G-1739T, and 1093A-1739T haplotypes, respectively. Case vs case = p value comparing haplotype frequency between Thai case and Chinese case. Case vs control = p value comparing haplotype frequency between case and control in each ethnic. a is Thai, b is Chinese and c is total. Control vs control = p value comparing haplotype frequency between Thai control and Chinese control.
###end p 22
###begin p 23
###xml 110 115 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 129 130 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 751 752 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
Comparison among haplotypes confirmed 1739C-->T as NPC susceptible mutation and excluded any other particular PIGR allele (table 3). First, whereas 1739C-->T did, no haplotype was associated with significant OR in all Thai, Chinese and Thai-Chinese populations. Second, there were haplotypes with 1739C as susceptible alleles such as GC in the Chinese and total and 1739T as protective alleles such as AT in the Thai, GT in the Chinese and both haplotypes in the total population. In addition, there was no significant haplotype with 1739C as a protective allele or 1739T associated with significant higher relative risk. Finally, the relationship between each haplotype was measured and the data obtained supported the importance of 1739C-->T (table 4). Whereas the ORs of the same 1739 nucleotides, between GC and AC or GT and AT, were not statistically significant, both GC and AC haplotypes conveyed a higher OR than GT and AT.
###end p 23
###begin p 24
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
Ethnic group adjusted odd ratios between each PIGR1093-1739 haplotype.
###end p 24
###begin p 25
Ethnic group adjusted odd ratios were calculated from the number of cases and controls of each haplotype in the first column by comparing with haplotype listed in the upper row. Numbers before () are odd ratios and within () are 95% confidence interval. GC, AC, GT, and AT are 1093G-1739C, 1093A-1739C, 1093G-1739T, and 1093A-1739T haplotypes, respectively.
###end p 25
###begin title 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
PIGR sequences of NPC patients
###end title 26
###begin p 27
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
By complete sequencing the coding region of the PIGR gene from 16 NPC patients with homozygous 1739C and upon comparison with the genomic DNA sequence AC098935 and AL359089 as well as with PIGR SNPs reported in genbank, the 2 SNPs at base pairs 1093 and 1739 were confirmed. No additional nonsynonymous mutation was identified. However, there were six positions of new synonymous SNPs, IVS1-59G-->A, IVS1-35G-->A, IVS4-3C-->T, 373C-->T, 549G-->A, and 1773C-->T.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 365 373 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGRIVS3</italic>
###xml 527 531 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 664 668 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 911 913 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 983 988 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
The SNPs and haplotypes case control association study implicated that the probability to develop NPC might altered by DNA variation of PIGR, with nucleotide 1739 playing this crucial part. PIGR has been assigned to 1q31 and comprises of 11 exons [18]. The 1093G-->A and 1739C-->T are located on exon 5 and 7, respectively. The physical distance between nucleotide PIGRIVS3-156, 1093 and 1739 were 25 and 2.5 kb, respectively. Thus the three SNPs were closely linked but they distinctly contributed to NPC development. Whereas PIGR1739C-->T exhibited a remarkably significant relative risk of NPC development among all Thai and Chinese populations, association of PIGRIVS3-156G-->T and 1093G-->A was not shown. Our data have provided an example that conclusions drawn from association studies aimed at identifying a susceptibility gene without related functional SNP should be interpreted with extreme caution [23]. If 1739C-->T had not been chosen for this study, the importance of PIGR as an NPC susceptibility gene would have been misconstrued.
###end p 29
###begin p 30
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 391 393 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 394 396 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 130 133 <span type="species:ncbi:10376">EBV</span>
###xml 521 524 <span type="species:ncbi:10376">EBV</span>
###xml 609 612 <span type="species:ncbi:10376">EBV</span>
###xml 704 707 <span type="species:ncbi:10376">EBV</span>
The manner, in which this PIGR1739C-->T alters cellular movement of the IgA complex and consequently increases the possibility of EBV associate NPC development, remains to be elucidated. The polymorphism is a missense mutation altering the amino acid alanine to valine. The codon is located on exon 7, which is adjacent to the endoproteolytic cleavage site of the PIGR extracellular domain [29,30]. As a result, homozygous 1739C of the PIGR of individuals from high-risk ethnic origin may alter efficiency to release IgA-EBV complex and consequently, their NEs would have higher possibility to be infected by EBV. Future functional study is needed to elucidate how the polymorphisms in relationship with EBV biology alter the NPC susceptibility.
###end p 30
###begin p 31
###xml 124 126 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 141 146 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 501 506 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 630 633 <span type="species:ncbi:10376">EBV</span>
It is important to note that the 1739C-->T mutation can also be found in other lower risk ethnic groups, such as Caucasian [30]. Hence, this PIGR nucleotide, despite a remarkably association with NPC, cannot account for its unique endemic distribution. On the other hand, this gene may be critical only for members of high-risk populations, to develop NPC as a consequence of other endemic genetic and/or environmental risk factors. Additionally, it is also interesting to find out whether the SNP on PIGR is a risk-associated factor affecting the disease susceptibility in the Caucasian population where NPC is rare and not 100% EBV related.
###end p 31
###begin p 32
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 63 66 <span type="species:ncbi:10376">EBV</span>
###xml 195 200 <span type="species:ncbi:9606">Human</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 350 353 <span type="species:ncbi:10376">EBV</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 448 453 <span type="species:ncbi:9606">human</span>
PIGR plays a crucial role in mucosal immunity not only against EBV, but also pneumococcal infection by facilitating transporting polymeric immunoglobulin transport across the mucosal epithelium. Human PIGR can bind to a major pneumococcal adhesion and enhanced pneumococcal adherence and invasion [17]. In other words, two important human pathogens, EBV and pneumococcus, employ the same human antibody transport protein, PIGR, to cause two common human diseases at the same tissue type, NE. The manner in which these two organisms interact with host (DNA) variation in vivo and what are the consequences might be on a global evolutionary scale will be very interesting subject for further investigation.
###end p 32
###begin title 33
Conclusions
###end title 33
###begin p 34
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 126 129 <span type="species:ncbi:10376">EBV</span>
###xml 537 540 <span type="species:ncbi:10376">EBV</span>
###xml 549 552 <span type="species:ncbi:10376">EBV</span>
###xml 768 771 <span type="species:ncbi:10376">EBV</span>
The aim of this research was to explore risk associations between polymorphisms of two hypothesized nasopharyngeal epithelial EBV receptors, CR2 and PIGR, and NPC susceptibility The results obtained indicated that PIGR is an NPC susceptibility gene. The risk association pertaining to each ethnic group was detected for homozygous PIGR1739C with a significant ethnic group adjusted OR (95%CI) of 2.71(1.72-4.23) and p < 0.00001. This suggested genetic evidence leading to hypothesize a possibility of PIGR as the epithelial receptor for EBV via IgA-EBV complex transcytosis failure. More importantly, the PIGR1739C-->T is a missense mutation changing alanine to valine near endoproteolytic cleavage site. This variant could alter the efficiency of PIGR to release IgA-EBV complex and consequently increase the susceptibility of populations in endemic areas to develop NPC.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
Sample collection
###end title 36
###begin p 37
###xml 138 146 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
###xml 1047 1054 <span type="species:ncbi:9606">patient</span>
After having obtained the subjects' informed consent as to the purpose of the study blood samples were collected by venipuncture from NPC patients and controls. The patients and controls were interviewed and then separated into three groups, Thai, Chinese, and Thai-Chinese, respectively, based on the ethnic origins of their grandparents. If their ancestors, including their great grandparents, originated from China, they were considered Chinese. On the other hand, if their ancestors originated from Thailand, they were defined as Thai. In addition, if their ancestors originated from Thailand and China, they were defined as Thai-Chinese. Conclusively, 104 Thai, 107 Chinese and 106 Thai-Chinese were enrolled in the control group whereas the NPC patients comprised 110 Thai, 42 Chinese and 23 Thai-Chinese. The 175 patients were recruited at King Chulalongkorn Memorial Hospital between 1994 and 2001. They were permanent residents in Bangkok or the central part of Thailand. All cases were Thai, Chinese or Thai-Chinese. The tumors of every patient was histologically ascertained as NPC type II or III, according to WHO classification. The 317 controls were healthy blood donors from Thai Red Cross Society, locating in the King Chulalongkorn Memorial Hospital. All had permanent resident in Bangkok or the central part of Thailand and those previously diagnosed with NPC or belonging to an ethnic group other than Thai, Chinese or Thai-Chinese had been excluded. The male:female ratio among the cases was 1.8:1 and among the controls 1.6:1, respectively. Their DNA was isolated by proteinase K and incubated overnight at 50degreesC, followed by phenol/chloroform extraction and ethanol precipitation.
###end p 37
###begin title 38
SNP's information
###end title 38
###begin p 39
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 29 33 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 47 51 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 65 69 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 93 96 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 131 133 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 139 143 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 170 172 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 235 239 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 248 252 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
Four SNPs, CR2IVS2-848C-->T, PIGRIVS3-156G-->T,PIGR1093G-->A and PIGR1739C-->T, were chosen. CR2IVS2-848C-->T located in intron 2 [24] and PIGRIVS3-156G-->T in intron3, [25] had previously been published as RFLP polymorphisms, whereas PIGR1093 and PIGR1739 were selected from a SNPs database.
###end p 39
###begin title 40
PCR-RFLP
###end title 40
###begin p 41
###xml 110 113 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 128 132 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 151 155 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 301 304 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 384 388 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 483 487 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 707 709 689 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 766 769 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 1008 1012 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 1168 1172 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 1485 1490 1407 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TaqI </italic>
###xml 1494 1497 1416 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2</italic>
###xml 1512 1518 1432 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PvuII </italic>
###xml 1522 1526 1442 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 1545 1550 1463 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HgaI </italic>
###xml 1554 1558 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 1612 1617 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TaqI </italic>
###xml 1647 1653 1551 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PvuII </italic>
###xml 1657 1661 1561 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HgaI</italic>
PCR reactions were performed, using Perkin-Elmer/DNA Thermal cycle480, in a total volume of 50 mul to amplify CR2IVS2-848C-->T, PIGRIVS3-156G-->T, and PIGR1739C-->T. The reaction mixtures consisted of 100 ng of genomic DNA and the following set of primers at the respective concentrations: 0.1 muM of CR2IVS2-848C-->T primers (5'-CTTTCTGTGCAGACCACGTT-3' and 5'-GATCTATGGTAGCCAGTTGG-3'PIGRIVS3-156G-->T primers (5'-TCAGCCAGGGTAAGGATCC-3' and 5'-TGATGGTCACCGTTCTGCC-3'), or 0.2 muM of PIGR1739C-->T primers (5'-GGGTCCCGCGATGTCAGCCTAG-3' and 5'-TTCTCCGAGTGGGGAGCCTT-3'). The DNA samples were amplified in the presence of 200 mumol dNTPs, 5 mul of 10X PCR buffer (20 muM Tris-HCl pH 8.4, 50 mM KCl), 1.5 mM MgCl2 and 4U Taq DNA polymerase (Gibco). The PCR condition for CR2IVS2-848C-->T comprised an initiation denaturation step at 94degreesC for 4 minutes, followed by 35 cycles of 95degreesC for 1 minute, 55degreesC for 1 minute, 72degreesC for 2 minutes and final extension step at 72degreesC for 7 minutes. PIGRIVS3-156G-->T was amplified 40 cycles at an annealing temperature of 60degreesC for 1 minute, and extension at 72degreesC for 3 minutes. The conditions for PIGR1739C-->T was 35 cycles at 60degreesC annealing temperature for 1 minute and extension at 72degreesC for 1 minute. Subsequently, RFLP analysis was performed on 20 microliters each of the respective PCR products by subjecting them to the following restriction enzymes (New England Biolabs) at a 10U concentration: TaqI for CR2IVS2-848C-->T, PvuII for PIGRIVS3-156G-->T, and HgaI for PIGR1739C-->T with overnight incubation at 65degreesC for TaqI and at 37degreesC for both of PvuII and HgaI. The resulting products were further analyzed by 2% agarose gel electrophoresis.
###end p 41
###begin title 42
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
ARMS of PIGR1093G-->A
###end title 42
###begin p 43
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR</italic>
###xml 475 476 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The Amplification Refractory Mutation System (ARMS) [26] was used to detect SNP PIGR1093G-->A. The primers can be divided into 2 sets, A and B. Set A primers comprised of 1093Fa and 1093R (GCCCCACTGTGGTGAAGGGGGTGGCAGGTG and ACTGGGCCTTAACCCACCCC), whereas 1093Fb (GCCCCACTGTGGTGAAGGGGGTGG CAGGTA) and 1093R were mixed in set B. For each sample, the PCR reaction was performed in duplicate, set A and B, in a total volume of 50 mul containing 100 ng of genomic DNA, 1.5 mM MgCl2, 5 mul of 10X buffer (20 muM Tris-HCl pH 8.4, 50 mM KCl), 4U Taq Gold DNA polymerase (Perkin Elmer) and 0.3 muM of primer set A or set B. PCR conditions included initial denaturation at 95degreesC for 10 minutes followed by 30 cycles of 95degreesC for 1 minute, 65degreesC for 1 minute, 72degreesC for 1 minutes and final extension for 72degreesC for 7 minutes in a Perkin-Elmer/DNA thermal Cycle 480. Each SNP was investigated by 2% agarose gel electrophoresis for complementarity of the PCR product with the 3' nucleotide of primers set A and/or set B.
###end p 43
###begin title 44
Statistical analysis
###end title 44
###begin p 45
###xml 169 173 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR2 </italic>
###xml 176 181 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 692 694 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 872 874 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1327 1328 1325 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1408 1410 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Both cases and controls were subdivided based on ethnic, sex and age at sampling (i.e., <30, 30-49, 50-69, >/= 70 years). The association between certain alleles of the CR2 or PIGR and NPC development was estimated by the statcalc from Epi info 2000 program  to calculate the odds ratio (OR) and 95% confidence interval (CI), Mantel-Haenszel chi squares and associated p values. Mantel-Haenszel weighted OR, summary chi square and p value were adjusted for the confounding effect of ethnic, and/or age and sex by combining stratified 2 x 2 tables. The effect exerted by genotype was estimated as if autosomal inheritance according to actual number of alleles contributed to a significant OR [27]. Haplotype frequencies for pairs of alleles, as well as Chi square values for allele associations were estimated by the Estimating Haplotype-frequencies (EH) software program [28]. The number of each haplotype from each ethnic were estimated based on the allele frequencies multiplied by the number of cases. The haplotype numbers of all the cases as well as controls were summation of the haplotype numbers of Thai, Chinese and Thai-Chinese groups. The association between each haplotype and NPC development was calculated based on the OR using Epi info 2000 program. The haplotype differences between groups were estimated by T(x2/2) = In(L, group1)+In(L, group2)-In(L, group1+group2) as previously described [28].
###end p 45
###begin title 46
Sequencing
###end title 46
###begin p 47
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGR </italic>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
All 11 exons of PIGR genomic DNA were amplified from DNA samples of 16 unrelated patients. Each exon was amplified by a pair of primers locating on the following positions in relation with nucleotide number AL359089: 93732C-93751G and 94163A-93782C, 99668C-99687T and 100025A-100044C, 100724C-100743T and 101427C-101446T, 102578A-102597G and 103454C-103473A, 104403C-104422A and 105039T-105058A, 105584C-105604G and 106080G-106099G, 107094C-107113A and 107518G-107537C, 107737G-107756C and 108066C-108085C, 108524A-108543T and 109039G-109059T, and 109935G-109954G) and 110656G-110675C. Subsequently, PCR products were purified and directly sequenced in both directions by dye terminators into cycle-sequencing products.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
###xml 169 177 <span type="species:ncbi:9606">patients</span>
RH and NK gathered case and control samples as well as informations and performed the molecular genotyping experiments and statistical analysis. KS, PS and NV collected patients and clinical data. AJ sequenced the whole gene, reviewed statistical analysis methodology and partly wrote the articles. AM hypothesized, designed the experiments and interpreted the genotyping, statistical, sequencing results and wrote the article.
###end p 49
###begin title 50
Acknowledgment
###end title 50
###begin p 51
###xml 424 432 <span type="species:ncbi:9606">patients</span>
The study was supported by the Molecular Biology Project, Faculty of Medicine, Chulalongkorn University, the National Science and Technology Development Agency, and the Thailand Research Fund. The authors are deeply indebted to the staff of the Department of Otolaryngology and the Radiotherapy Section, Department of Radiology, Faculty of Medicine, Chulalongkorn University and National Blood Center for the recruitment of patients and collection of materials. The authors thank Ms Petra Hirsh and Dr Mettanando Bhikkhu for comments and advises.
###end p 51
###begin article-title 52
Molecular mechanisms of nasopharyngeal carcinoma development.
###end article-title 52
###begin article-title 53
The aetiology of nasopharyngeal carcinoma.
###end article-title 53
###begin article-title 54
Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity.
###end article-title 54
###begin article-title 55
###xml 76 94 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.
###end article-title 55
###begin article-title 56
###xml 45 63 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
###end article-title 56
###begin article-title 57
Diet, living conditions and nasopharyngeal carcinoma in Tunisia - a case-control study.
###end article-title 57
###begin article-title 58
Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China.
###end article-title 58
###begin article-title 59
Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.
###end article-title 59
###begin article-title 60
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human leucocyte antigens and nasopharyngeal carcinoma.
###end article-title 60
###begin article-title 61
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.
###end article-title 61
###begin article-title 62
Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study.
###end article-title 62
###begin article-title 63
Cancer in the Far East.
###end article-title 63
###begin article-title 64
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
###end article-title 64
###begin article-title 65
###xml 40 58 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.
###end article-title 65
###begin article-title 66
###xml 45 63 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.
###end article-title 66
###begin article-title 67
###xml 96 101 <span type="species:ncbi:9606">human</span>
Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells.
###end article-title 67
###begin article-title 68
###xml 70 75 <span type="species:ncbi:9606">human</span>
The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells.
###end article-title 68
###begin article-title 69
Regulation of the formation and external transport of secretory immunoglobulins.
###end article-title 69
###begin article-title 70
###xml 110 128 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus.
###end article-title 70
###begin article-title 71
The basolateral sorting signal of the polymeric immunoglobulin receptor contains two functional domains.
###end article-title 71
###begin article-title 72
###xml 17 35 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
###end article-title 72
###begin article-title 73
###xml 21 39 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 92 95 <span type="species:ncbi:9606">men</span>
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.
###end article-title 73
###begin article-title 74
Candidate-gene approaches for studying complex genetic traits: practical considerations.
###end article-title 74
###begin article-title 75
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 56 74 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
###end article-title 75
###begin article-title 76
###xml 63 68 <span type="species:ncbi:9606">human</span>
Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor).
###end article-title 76
###begin article-title 77
###xml 20 25 <span type="species:ncbi:9606">human</span>
Current protocol in human genetic.
###end article-title 77
###begin article-title 78
###xml 60 65 <span type="species:ncbi:9606">Woman</span>
CYP17 Promoter Polymorphism and Breast Cancer in Australian Woman Under Age Forty Years.
###end article-title 78
###begin article-title 79
Model-free analysis and permutation tests for allelic associations.
###end article-title 79
###begin article-title 80
Intracellular targetting signals of polymeric immunoglobulin receptors are highly conserved between species.
###end article-title 80
###begin article-title 81
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human free secretory component of the polymeric immunoglobulin receptor.
###end article-title 81

